"Hope and Progress" takes an army – 30,000 of them!

As you may already have read, team members of Fight Colorectal Cancer which includes Staff, Board, Grassroots Action Committee (GAC) along with our Medical Advisory Board (MAB) have been in full swing at the Chicago 2013 Gastrointestinal Cancers Symposium. The American Society of Clinical Oncology®…

Read Full Post

Patient Involvement in Decision-Making: A long way to go

This week brings some excellent reading about why and how to educate patients so they can help make better decisions about their own care. What happens when patients get to read their own medical records? The Oct. 2nd  Annals of Internal Medicine published two editorials…

Read Full Post

Doctors Urged to Talk Discuss Palliative Care

Soon after diagnosing a patient with advanced cancer, a doctor should begin discussing options for palliative care—the management of symptoms—according to a new policy statement from the American Society of Clinical Oncology (ASCO).  ASCO also released a new, free guide called Advanced Cancer Care Planning…

Read Full Post

ASCO Advises Oncologists: Test for KRAS Mutations

The American Society for Clinical Oncology (ASCO) has published a provisional clinical opinion (PCO) advising doctors to test patients with colorectal cancer for KRAS mutations before treating them with medicines that include Erbitux® (cetuximab) or Vectibix™ (panitumumab). The consensus of experts who reviewed recent research was…

Read Full Post

ASCO Issues Opinion on KRAS Testing

An panel of experts at the American Society of Clinical Oncology recommends that all patients who are being considered for anti-EGFR therapy have their tumors tested for the KRAS gene. If mutations are found, the panel says they should not be treated with Erbitux® (cetuximab)…

Read Full Post
Page 2 of 3123